1. Home
  2. Myelofibrosis
  Subject:

Myelofibrosis   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Janus kinase 2 Myeloproliferative neoplasm Polycythemia vera Essential thrombocytosis Thrombosis Splenomegaly Bone marrow Allele Thrombocytopenia Ruxolitinib Myelofibrosis Hydroxycarbamide Syndrome Stent Infarction Disease Platelet CT scan Portal hypertension Lymphadenopathy Gene Haematopoiesis Magnetic resonance imaging Flow cytometry Protein Single-nucleotide polymorphism Polymerase chain reaction DNA Zygosity Anemia Neutropenia Fever Chemotherapy Janus kinase Placebo
RELATED SUBJECTS:
The publications listed also have these subjects
Janus kinase 2  8 times
Myeloproliferative neoplasm  7 times
Thrombosis  3 times
Splenomegaly  3 times
Bone marrow  3 times
Allele  3 times
Thrombocytopenia  2 times
Mutation  2 times
Haematopoiesis  2 times
Fibrosis  2 times
Disease  2 times
DNA sequencing  2 times
Anemia  2 times
Venous thrombosis  1 time
Telomerase  1 time
Syndrome  1 time
Spleen  1 time
Shock (circulatory)  1 time
Sepsis  1 time
Pneumonia  1 time
Platelet  1 time
Placebo  1 time
Philadelphia  1 time
Phenotype  1 time
P53  1 time
Multiple myeloma  1 time
Medical ultrasound  1 time
Lymphoma  1 time
Lymph node  1 time
Leukocytosis  1 time
Leukemia  1 time
Kinase  1 time
Karyotype  1 time
Janus  1 time
Interferon  1 time
IDH1  1 time
Hematoma  1 time
Enzyme inhibitor  1 time
EZH2  1 time
Diarrhea  1 time
Cytokine  1 time
Collagen  1 time
Carcinoma  1 time
Canada  1 time
CT scan  1 time
Bone marrow examination  1 time
Bleeding  1 time
Biopsy  1 time
Australia  1 time
Aspirin  1 time
Acute myeloid leukemia  1 time

Publications tagged with this subject: 13

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

2. Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature

3. Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms

4. Bone Marrow Disease Profile in Geriatric Patients: An Institutional Experience

5. Can pegylated interferon improve the outcome of polycythemia vera patients?

6. Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory

7. Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden

8. A case of perirenal extramedullary hematopoiesis in a patient with primary myelofibrosis

9. Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender

10. Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

11. The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review

12. Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis

13. Pharmacotherapy of Myelofibrosis


Questions?

Drop us a message.